Inhalation Sciences Sweden AB Stock OTC Markets
Stocks
INHSF
SE0009983893
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | - |
| 07-29 | Inhalation Sciences secures financing of up to €0.4m | FW |
| 06-16 | Inhalation Sciences Secures SEK 0.4m Research Grant | FW |
| Market Cap | 9.22M 966K 840K 782K 718K 1.36M 92.24M 1.38M 3.62M 45.92M 3.63M 3.55M 154M | P/E 2024 |
-12.8x | P/E 2025 | -12.4x |
|---|---|---|---|---|---|
| Enterprise Value | 6.38M 669K 582K 542K 497K 939K 63.9M 954K 2.51M 31.81M 2.51M 2.46M 107M | EV / Sales 2024 |
5.6x | EV / Sales 2025 | 55x |
| Free-Float |
94.25% | Yield 2024 * |
-
| Yield 2025 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Manoush Masarrat
CEO | Chief Executive Officer | - | 2019-09-15 |
Per Magnus Gerde
CTO | Chief Tech/Sci/R&D Officer | - | 2004-12-31 |
Ulf Wedenberg
PRN | Corporate Officer/Principal | - | 2025-06-01 |
| Director | Title | Age | Since |
|---|---|---|---|
Per Magnus Gerde
BRD | Director/Board Member | - | 2004-12-31 |
Jan Hellqvist
BRD | Director/Board Member | - | 2022-08-31 |
Ulf Ericsson
BRD | Director/Board Member | - | 2024-08-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 1.16M | |
| -0.43% | +1.06% | +22.80% | +4.67% | 214B | |
| -0.61% | +1.82% | -1.11% | -23.56% | 138B | |
| +0.10% | +4.69% | -26.56% | +8.92% | 125B | |
| +1.59% | +5.60% | -55.46% | -9.87% | 68.37B | |
| -0.98% | +4.16% | +8.52% | +4.87% | 50.05B | |
| -0.91% | +5.13% | -22.07% | -30.22% | 47.67B | |
| -0.25% | -0.14% | +20.52% | +13.63% | 39.18B | |
| -0.79% | +0.70% | +30.67% | +36.60% | 37.34B | |
| -2.75% | +12.28% | -4.63% | -12.79% | 31.59B | |
| Average | -0.50% | +3.24% | -3.03% | -0.86% | 83.46B | |
| Weighted average by Cap. | -0.36% | +2.10% | -1.59% | -2.01% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 11.05M 1.16M 1.01M 937K 860K 1.62M 111M 1.65M 4.34M 55.05M 4.35M 4.25M 185M | 3.04M 319K 277K 258K 237K 447K 30.44M 454K 1.19M 15.15M 1.2M 1.17M 50.81M |
| Net income | -5.15M -540K -469K -437K -401K -757K -51.52M -769K -2.02M -25.65M -2.03M -1.98M -86M | -10.16M -1.07M -926K -862K -791K -1.49M -102M -1.52M -3.99M -50.63M -4M -3.91M -170M |
| Net Debt | -4M -420K -365K -340K -312K -589K -40.07M -598K -1.57M -19.95M -1.58M -1.54M -66.88M | -2.83M -297K -258K -240K -221K -416K -28.34M -423K -1.11M -14.11M -1.11M -1.09M -47.3M |
Employees
5
Calendar
Net sales - Rate of surprise
- Stock Market
- Stocks
- ISAB Stock
- INHSF Stock
Select your edition
All financial news and data tailored to specific country editions
